Today: 7 February 2026
Subscribe

Wells Fargo stock slips as Fed minutes loom in thin year-end trading

Wells Fargo stock slips as Fed minutes loom in thin year-end trading

NEW YORK, December 30, 2025, 13:55 ET — Regular session. Wells Fargo & Company shares slipped on Tuesday as U.S. financial stocks eased in holiday-thin trading ahead of the Federal Reserve’s meeting minutes. At 1:55 p.m. ET, Wells Fargo (NYSE:WFC) was down about 0.4% at $94.15, after trading between $94.00 and $95.00 on the session. Reuters The move matters because bank stocks tend to key off interest-rate expectations. Rates drive net interest income — the spread between what banks earn on loans and what they pay on deposits — and even small changes in that spread can swing earnings forecasts.
30 December 2025
···
Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

NEW YORK, December 30, 2025, 13:50 ET — Regular session Pfizer Inc (NYSE:PFE) shares were up about 0.1% at $25.03 in afternoon trading on Tuesday, after moving between $24.92 and $25.10. TD Cowen reiterated its Hold rating and kept a $30 price target, pointing to negative trends in its model through 2030 despite the stock’s dividend yield near 7%. Investing.com The call lands as investors weigh Pfizer’s latest 2026 targets after the drugmaker projected revenue of $59.5 billion to $62.5 billion next year and adjusted earnings of $2.80 to $3.00 a share. “Adjusted” earnings strip out certain items the company
30 December 2025
··
Freshpet stock slides as Fed minutes loom in thin year-end trade (FRPT)

Freshpet stock slides as Fed minutes loom in thin year-end trade (FRPT)

NEW YORK, December 30, 2025, 1:59 PM ET — Regular session Freshpet, Inc. shares were down 3.5% at $60.84 by 1:59 p.m. ET on Tuesday, extending a choppy stretch for the pet food maker’s stock. The slide stood out against an otherwise muted session, a reminder that thinner year-end liquidity can exaggerate moves in single names. The stock’s drop also comes hours before the Federal Reserve releases minutes from its December policy meeting at 2 p.m. ET — a closely watched readout that can shift rate expectations and, by extension, valuations for stocks priced on future growth. https://www.reuters.com/business/final-fed-minutes-2025-shed-light-policy-divisions-2025-12-30/ U.S. stocks
30 December 2025
··
GMAB stock slides as Genmab scraps late-stage acasunlimab cancer therapy

GMAB stock slides as Genmab scraps late-stage acasunlimab cancer therapy

NEW YORK, December 30, 2025, 1:54 PM ET — Regular session Genmab A/S’s U.S.-listed shares (GMAB) fell 3.3% to $31.45 in Tuesday’s regular session. The stock traded between $31.40 and $32.06 after opening at $31.98, with about 1.9 million shares changing hands. The move keeps attention on Genmab’s pipeline as investors reassess which late-stage assets can power growth. Dropping a late-stage program can change a biotech’s outlook quickly because those trials sit closest to potential approvals and revenue. Genmab said on Monday it will discontinue further clinical development of acasunlimab after a portfolio review, citing a more competitive landscape. “After
30 December 2025
··
Lionsgate Studios (LION) stock slides today after insider sales hit the tape

Lionsgate Studios (LION) stock slides today after insider sales hit the tape

NEW YORK, December 30, 2025, 13:49 ET — Regular session Lionsgate Studios Corp shares fell 3.4% on Tuesday, retreating after filings showed two top executives sold stock late this month. The stock was down 32.5 cents at $9.105, after trading between $9.06 and $9.45. The disclosures landed with the stock near the top of its 52-week range of $5.55 to $9.46. That has made the name more sensitive to any sign of selling pressure heading into year-end. StockAnalysis Form 4 filings — mandatory SEC reports that disclose insider buying and selling — can move shares in the short term because
30 December 2025
·
Natural gas price steadies near $4 as UNG stock climbs; traders await fresh U.S. storage data

Natural gas price steadies near $4 as UNG stock climbs; traders await fresh U.S. storage data

NEW YORK, December 30, 2025, 13:35 ET — Regular session Shares of United States Natural Gas Fund, LP (UNG) climbed on Tuesday as U.S. natural gas prices steadied following a volatile contract rollover. UNG was up 1.6% at $13.26 in midday trading. The move matters because the market is deep in the winter demand season, when small shifts in temperature forecasts can quickly change heating demand. The front-month futures rollover also tends to concentrate liquidity and repositioning into a single contract, which can sharpen price swings. Government data released Monday showed working gas in storage across the Lower 48 states
30 December 2025
···
Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts

Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts

NEW YORK, December 30, 2025, 13:43 ET — Regular session Shares of Energy Fuels Inc fell 3.5% to $14.55 in afternoon trading on Tuesday. The uranium miner lagged peers, with Uranium Energy down about 1.9% while Cameco was little changed and MP Materials slipped about 1.3%. Energy Fuels traded about 5.9 million shares and ranged between $14.30 and $15.28. The pullback matters because uranium stocks have been swinging on fresh evidence of supply discipline, contract signings and realized pricing. Investors want proof that producers can turn high commodity prices into durable cash flow, not just headlines. Energy Fuels is a
30 December 2025
··
AI stocks today: Nvidia AI21 buyout talk hits tape as Meta climbs on Manus deal

AI stocks today: Nvidia AI21 buyout talk hits tape as Meta climbs on Manus deal

NEW YORK, December 30, 2025, 13:31 ET — Regular session Nvidia shares were nearly flat on Tuesday after an Israeli report said the AI-chip leader is in advanced talks to buy startup AI21 Labs for as much as $3 billion. Nvidia was down about 0.02% at $188.18 in early afternoon trade. Reuters The M&A chatter is landing in a holiday-thin week when investors are reassessing crowded AI trades after a late-2025 tech rally stalled on Monday. Strategists say the rotation has looked more like year-end rebalancing than panic selling. Reuters Traders are also bracing for macro headlines that can swing
30 December 2025
····
ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade

ADMA Biologics stock slides nearly 4% as biotech weakens in thin year-end trade

NEW YORK, December 30, 2025, 13:35 ET — Regular session Shares of ADMA Biologics fell 3.7% to $18.40 in afternoon trading on Tuesday, a steeper drop than the broader biotech group. The SPDR S&P Biotech ETF was down about 1.3%. The pullback came as U.S. stocks steadied in holiday-thin trading ahead of minutes from the Federal Reserve’s December policy meeting, after the central bank delivered a 25-basis-point cut this month. Mark Hackett, chief market strategist at Nationwide, described recent positioning as “a healthy rebalancing of allocations.” Reuters Biotechnology shares were among the laggards, with the NYSE Arca Biotechnology Index down
30 December 2025
·
Rivian stock drops nearly 6% as CEO share-sale filing hits the tape in thin year-end trade

Rivian stock drops nearly 6% as CEO share-sale filing hits the tape in thin year-end trade

NEW YORK, December 30, 2025, 13:30 ET — Regular session Rivian Automotive, Inc shares were down about 6% on Tuesday, pulling back in a light year-end session after a regulatory filing disclosed a stock sale by Chief Executive Officer Robert J. Scaringe. The move matters because thin holiday liquidity can exaggerate swings in high-volatility names, and investors have shifted back to demand signals and funding risk across electric-vehicle makers. Traders also had one eye on U.S. Federal Reserve minutes due later in the session and a closely watched Tesla update on quarterly deliveries, events that can reset risk appetite for
30 December 2025
···
XRP price today: Ripple token steadies near $1.88 as Fed minutes loom

XRP price today: Ripple token steadies near $1.88 as Fed minutes loom

NEW YORK, December 30, 2025, 13:30 ET — Regular session XRP rose about 1% on Tuesday to $1.88, hovering near the day’s high after slipping to $1.84 earlier in the session. Bitcoin gained about 0.8% and ether added roughly 1.3%. The steadier tone in the XRP price today comes as markets brace for the Federal Reserve’s December meeting minutes, due at 2 p.m. ET, which could reset expectations for U.S. rates into 2026. “The market doesn’t have a lot to work with right here,” Joseph Trevisani, a senior analyst at FX Street in New York, said. Reuters The minutes from
30 December 2025
·
Bitcoin price today steadies near $88,000 as Fed minutes loom; crypto stocks edge higher

Bitcoin price today steadies near $88,000 as Fed minutes loom; crypto stocks edge higher

NEW YORK, December 30, 2025, 1:29 PM ET — Regular session Bitcoin was up 0.8% at $88,320 on Tuesday afternoon in New York, steadying after recent choppy trading into the final days of the year. The move matters now because thin holiday trading has amplified swings across risk assets, leaving crypto sensitive to fresh signals on U.S. interest rates. Traders are watching whether the Federal Reserve’s next message cements expectations for more easing in 2026. Reuters+1 Markets get a key test at 2 p.m. ET when the Fed releases minutes from its December meeting — the detailed record of policymakers’
30 December 2025
·······
Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

Mineralys Therapeutics (MLYS) stock slides today as biotech weakens; FDA filing timeline in focus

NEW YORK, December 30, 2025, 13:38 ET — Regular session Shares of Mineralys Therapeutics Inc fell 3.3% to $35.61 by early afternoon on Tuesday, after touching a session low of $35.17. About 513,000 shares had changed hands, versus a previous close of $36.83. Mineralys has a market value of about $2.9 billion and remains up about 183% over the past 52 weeks, even after sliding about 25% from its 52-week high set in November. Analysts expect the company to stay loss-making in the near term; Barchart shows an average quarterly EPS estimate of -$0.57 and an expected next earnings date
30 December 2025
··
Silver price today: SLV jumps nearly 7% as silver rebounds after record-high rout

Silver price today: SLV jumps nearly 7% as silver rebounds after record-high rout

NEW YORK, December 30, 2025, 13:30 ET — Regular session Silver prices rebounded on Tuesday after a sharp pullback from record highs, pushing the iShares Silver Trust (SLV) up about 6.9% in New York trade. Spot silver was up 4.7% at $76.38 an ounce at 11:29 a.m. ET, a day after touching an all-time high of $83.62 and suffering its biggest one-day drop since August 2020. Analysts at Societe Generale pointed to CME Group’s move on Friday to raise the initial margin requirement for silver futures — the cash traders must post to hold positions — as a factor behind
30 December 2025
·
Gold price rebounds today as Fed minutes near; GLD and Newmont stocks climb

Gold price rebounds today as Fed minutes near; GLD and Newmont stocks climb

NEW YORK, December 30, 2025, 13:25 ET — Regular session Gold prices rebounded on Tuesday and gold-linked shares traded higher in midday U.S. dealings, as investors positioned ahead of Federal Reserve minutes due later in the session. Spot gold was around $4,373 an ounce, up about 1% on the day, according to Kitco data. Kitco The swing matters now because bullion’s late-year volatility is spilling into popular “gold proxy” trades — gold-backed ETFs that hold physical metal and large miners whose profits tend to move with the gold price. Gold is up about 66% in 2025, its biggest annual gain
30 December 2025
······
Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

NEW YORK, December 30, 2025, 13:33 ET — Regular session Rhythm Pharmaceuticals shares were down 4.2% at $107.85 at 1:33 p.m. ET on Tuesday, after trading as low as $106.65. The move matters because Rhythm is a single-product rare-disease biotech whose stock has tended to swing on regulatory and clinical milestones for Imcivree, its obesity drug. Investors are watching the company’s next U.S. Food and Drug Administration decision closely. With the next major catalyst still ahead, the stock can move sharply on broader risk sentiment in biotech, even when there is no fresh company news. The SPDR S&P Biotech ETF
30 December 2025
··
S&P 500 Slips Before Fed Minutes as Meta Rises on Manus AI Deal

S&P 500 Slips Before Fed Minutes as Meta Rises on Manus AI Deal

NEW YORK, December 30, 2025, 13:22 ET — Regular session U.S. stocks edged lower in holiday-thin trade on Tuesday, with the S&P 500 and Nasdaq near flat as investors waited for the Federal Reserve’s meeting minutes. Meta Platforms rose after saying it will buy AI startup Manus, helping support communication services shares. At 12:00 p.m. ET, the Dow fell 0.24%, the S&P 500 slipped 0.09% and the Nasdaq Composite eased 0.07%. Reuters The quiet tape matters because markets are closing out the year near record levels, and light volume can exaggerate otherwise small moves. The pause follows Monday’s pullback in
30 December 2025
····
Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading

Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading

NEW YORK, December 30, 2025, 13:34 ET — Regular session Warby Parker Inc (WRBY) shares fell about 3.9% to $22.11 in early afternoon trading on Tuesday, after ending Monday at $23.00. The stock opened at $22.90 and traded between $21.87 and $23.13, with nearly 3 million shares changing hands; the company is valued at about $3.4 billion. The slide comes with just a handful of sessions left in 2025, a stretch when trading often thins out and price moves can look outsized. Thin trading means fewer buyers and sellers, so routine position changes can move a stock more than usual.
30 December 2025
·
Dow Jones today: DJIA slips in thin year-end trade as Fed minutes loom

Dow Jones today: DJIA slips in thin year-end trade as Fed minutes loom

NEW YORK, December 30, 2025, 13:24 ET — Regular session The Dow Jones Industrial Average edged lower on Tuesday as investors kept positions tight ahead of Federal Reserve minutes in the final sessions of the year. The blue-chip index was down 57.44 points, or 0.12%, at 48,404.49 by 1:24 p.m. ET, while the S&P 500 and Nasdaq Composite were little changed, according to LSEG data. Reuters The muted trade matters now because year-end conditions can distort price action. With many desks lightly staffed and portfolios being rebalanced, even modest buying or selling can push indexes around more than usual. The
30 December 2025
·····
France vows stable electricity bills in 2026 — but new charges could still push costs up

France vows stable electricity bills in 2026 — but new charges could still push costs up

NEW YORK, December 30, 2025, 13:17 ET France’s economy ministry says most households should not see their electricity bills rise in 2026 and 2027 as the country enters a new pricing regime for nuclear power from Jan. 1. L’Energeek The reassurance comes just ahead of the expiry of ARENH, a long-running scheme that capped the price of part of EDF’s nuclear output and helped set the benchmark for retail electricity offers. The change matters now because it lands at the start of a new year, when households reset budgets and energy bills are a politically sensitive issue after the volatility
30 December 2025
·
1 … 655 656 657 658 659 … 1,632

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop